Latest Commercial Negotiations News

PMET Resources has secured crucial non-binding letters of support from Export Development Canada and Germany’s KfW IPEX-Bank, marking a key step toward financing its Shaakichiuwaanaan critical minerals project in Quebec ahead of an updated feasibility study.

Australian Oil Company Limited has completed its first crude oil lifting from the Emu Apple Oil Field, marking a key step in its Surat Basin development with steady production and active exploration underway.

KGL Resources delivers a robust Baseline Economic Model for its Jervois Copper-Silver-Gold Project, highlighting a pre-tax NPV8 of A$1.226 billion and a 37% IRR, underpinning imminent project financing and construction plans.

Pinnacle Minerals has exited its US critical minerals ventures, retaining key Australian and Canadian assets while bolstering its board and cash position to pursue strategic growth.

Elevra Lithium delivered a strong March 2026 quarter with record revenues, operational improvements at North American Lithium, and progress on multiple growth fronts, supported by a robust cash position.

Future Metals has unveiled a lower-risk, lower-capital pathway for its Panton PGM Project by leveraging the idle Savannah Plant, delivering upfront savings of around A$74 million and preserving long-term growth potential.

Vysarn Limited's joint venture with Kariyarra Aboriginal Corporation has been shortlisted by Water Corporation to submit a formal proposal for supplying bulk water to Port Hedland, progressing key regulatory approvals for the Kariyarra Water Scheme.

Condor Energy has agreed to acquire Jaguar Exploration’s 20% stake in the TEA 86 offshore Peru project, moving to full ownership. The deal, structured through performance shares, aims to simplify equity and support licence conversion and future partnerships.

Jade Gas Holdings has completed its appraisal program for the TTCBM Project in Mongolia, setting the stage for regulatory approvals and commercial development of a major domestic gas resource.

Paradigm Biopharmaceuticals reports a sharp rise in half-year losses as it intensifies investment in its pivotal Phase 3 trial for knee osteoarthritis, setting sights on a critical interim analysis in mid-2026. The company also expands its osteoarthritis pipeline and maintains strong funding amid a strengthening biotech sector.

Memphasys has lodged regulatory submissions for its Felix™ System in Australia and India, following CE Mark approval, while progressing UK market entry under the CE Mark transition framework.

State Gas Limited has independently certified a maiden 2P gas reserve of 30.2 PJ at its Rolleston West Project, underpinning plans for a 10TJ/day gas development. The company also raised $3.2 million through convertible notes to accelerate pre-development activities.